Medicament for administering to a patient by inhalation
Medicament contains (i) formoterol (and/or one or its physiologically acceptable salts and/or solvates) and (ii) budesonide separately or together can be administered simultaneously sequentially or separately by inhalation in the treatment of respiratory disorders. The ratio of formateol to budesoni...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | cze ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Medicament contains (i) formoterol (and/or one or its physiologically acceptable salts and/or solvates) and (ii) budesonide separately or together can be administered simultaneously sequentially or separately by inhalation in the treatment of respiratory disorders. The ratio of formateol to budesonide is pref. 1:4-1:70, used combined or separately. Suitable daily doses are 6-100(esp. 6-48) mg formoterol and 50-4800 (esp. 100-1600) micro-g budesonide divided into two doses a day.
L ivo pro pod n inhalac , kter obsahuje separ tn (i) formoterol nebo jeho fyziologicky p°ijatelnou s l, nebo solv t uveden soli nebo solv t formoterolu, a (ii) budesonid.\
The present invention relates to a medicament for administering to a patient by inhalation and which separately contains: i) formoterol or a physiologically acceptable salt thereof or a solvate of such salt or the formoterol solvate and ii) budesonide. |
|---|